Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.22 -0.08 (-6.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Price to Sales (2020 - 2021)

Updated

Alx Oncology Holdings' Price to Sales was 5626.15 in Q1 2021, up 317.3% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Price to Sales (2020 - 2021) Analysis & Trends

For FY2020, Price to Sales at Alx Oncology Holdings came in at 1348.09.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Alx Oncology Holdings 168.62 Mn 168.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 5,626.15
Dec 31, 2020 1,348.09
Sep 30, 2020 467.44
API Access

Alx Oncology Holdings Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALXO&period=max&api_key=YOUR_API_KEY